Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q3

2934.TEDINET S100UXBC
Period2023-06-01 → 2024-02-29
Filed2024-12-11
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed

Amends S100T9GJ. Amended by S100UXGM (2024-12-11).

Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥12.4bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥16.8bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥12.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income−¥542m2023-06-01 → 2024-02-29Cons.Operating income
Operating income−¥718m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income−¥552m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income−¥1.8bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥737m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax−¥554m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax−¥738m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)−¥638m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.9bn2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥615m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income−¥632m2023-06-01 → 2024-02-29Cons.Profit loss
Net income−¥577m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥8.7bnat 2024-02-29Cons.Assets
Total assets¥7.2bnat 2023-05-31Cons.Assets
Total assets¥7.8bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥5.9bnat 2024-02-29Cons.Liabilities
Total liabilities¥4.5bnat 2023-05-31Cons.Liabilities
Net assets / equity¥2.8bnat 2024-02-29Cons.Net assets
Net assets / equity¥2.7bnat 2023-05-31Cons.Net assets
Net assets / equity¥4.0bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥1.2bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥1.6bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥-131.132023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-71.252023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-410.62022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-133.62022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-55.92022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio29.2%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio34.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.0%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-06-01 → 2024-02-29−¥172m
Reconciling Itemsreconcilingrevenue intersegment2023-06-01 → 2024-02-29−¥172m
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥438m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥4.2bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥4.1bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥165m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2023-06-01 → 2024-02-29¥27m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥150,000
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥72m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥5.3bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥5.3bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2023-06-01 → 2024-02-29¥7m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥59m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥12.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-06-01 → 2024-02-29¥172m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29−¥103m
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥385m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥4.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.9bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥139m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥19m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥224m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥458,000
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥576m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥12.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥139m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28−¥333m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 352
ItemContextValueUnit
Gross profitPrior1YTDDuration5112327000JPY
Gross profitCurrentYTDDuration5911744000JPY
Selling general and administrative expensesPrior1YTDDuration5830508000JPY
Selling general and administrative expensesCurrentYTDDuration6453407000JPY
Operating incomePrior1YTDDuration-718181000JPY
Operating incomeCurrentYTDDuration-541662000JPY
Interest income noiPrior1YTDDuration1024000JPY
Interest income noiCurrentYTDDuration402000JPY
Dividends income noiPrior1YTDDuration72000JPY
Dividends income noiCurrentYTDDuration2000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration－JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration6267000JPY
Other noiPrior1YTDDuration4227000JPY
Other noiCurrentYTDDuration5346000JPY
Non operating incomePrior1YTDDuration5323000JPY
Non operating incomeCurrentYTDDuration12019000JPY
Interest expenses noePrior1YTDDuration8931000JPY
Interest expenses noeCurrentYTDDuration16466000JPY
Provision of allowance for doubtful accounts noePrior1YTDDuration660000JPY
Provision of allowance for doubtful accounts noeCurrentYTDDuration651000JPY
Share acquisition rights issuance costs noePrior1YTDDuration9384000JPY
Share acquisition rights issuance costs noeCurrentYTDDuration－JPY
Other noePrior1YTDDuration4927000JPY
Other noeCurrentYTDDuration5034000JPY
Non operating expensesPrior1YTDDuration23903000JPY
Non operating expensesCurrentYTDDuration22152000JPY
Ordinary incomePrior1YTDDuration-736761000JPY
Ordinary incomeCurrentYTDDuration-551795000JPY
Gain on negative goodwill eiPrior1YTDDuration－JPY
Gain on negative goodwill eiCurrentYTDDuration259000JPY
Other eiPrior1YTDDuration－JPY
Other eiCurrentYTDDuration70000JPY
Extraordinary incomePrior1YTDDuration－JPY
Extraordinary incomeCurrentYTDDuration329000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration907000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration2209000JPY
Extraordinary lossPrior1YTDDuration907000JPY
Extraordinary lossCurrentYTDDuration2209000JPY
Income before income taxesPrior1YTDDuration-737669000JPY
Income before income taxesCurrentYTDDuration-553675000JPY
Income taxes currentPrior1YTDDuration95567000JPY
Income taxes currentCurrentYTDDuration103627000JPY
Income taxes deferredPrior1YTDDuration-256313000JPY
Income taxes deferredCurrentYTDDuration-25047000JPY
Income taxesPrior1YTDDuration-160745000JPY
Income taxesCurrentYTDDuration78580000JPY
Profit lossPrior1YTDDuration-576923000JPY
Profit lossCurrentYTDDuration-632255000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration38348000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration5269000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass